Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer

Gynecologic Oncology

Volumn 110, Issue 2, 2008, Pages 152-157

  Cohn, David E ^a   Hall, Nathan C ^b   Povoski, Stephen P ^a   Seamon, Leigh G ^a   Farrar, William B ^a   Martin Jr , Edward W ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Section of PET   (United States)

Author keywords

18F FDG; Cytoreduction; Ovarian cancer; PET

Indexed keywords

CARBOPLATIN; FLUORODEOXYGLUCOSE F 18; PACLITAXEL;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC IMAGING; EPITHELIUM TUMOR; FEMALE; GAMMA PROBE; HUMAN; HYPERMETABOLISM; INGUINAL LYMPH NODE; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; MECHANICAL PROBE; MULTIPLE CYCLE TREATMENT; OVARY ADENOCARCINOMA; OVARY CANCER; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT CANCER; SINGLE DRUG DOSE; TUMOR LOCALIZATION;

ADULT; CYSTADENOCARCINOMA, SEROUS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INTRAOPERATIVE CARE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 47249151313     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.04.026     Document Type: Article

References (24)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics. CA Cancer J Clin 57 (2007) 43-66
2. Bristow R.E., del Carmen M.G., Pannu H.K., Cohade C., Zahurak M.L., Fishman E.K., et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 90 (2003) 519-528.
3. Sebastian S., Lee S.I., Horowitz N.S., Scott J.A., Fischman A.J., Simeone J.F., et al. PET-CT vs. CT alone in ovarian cancer. Abdom Imaging 33 (2008) 112-118
4. Eisenkop S.M., Friedman R.L., and Wang H.J. Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study. Cancer 76 (1995) 1606-1614
5. 18F-FDG handheld gamma probe detection for tumor localization and verification of complete tumor resection in breast cancer. World J Surg Oncol 5 (2007) 143.
6. Martin Jr. E.W., and Thurston M.O. The use of monoclonal antibodies (MAbs) and the development of an intraoperative hand-held probe for cancer detection. Cancer Invest 14 (1996) 560-571
7. Zimny M., Siggelkow W., Schröder W., Nowak B., Biemann S., Rath W., et al. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 83 (2001) 310-315.
8. Karlan B.Y., Hawkins R., Hoh C., Lee M., Tse N., Cane P., et al. Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-d-glucose can detect recurrent ovarian carcinoma. Gynecol Oncol 51 (1993) 175-181
9. Bristow R.E., Gauntly II R.L., Pannu H.K., Schulick R.D., Fishman E.K., and Wahl R.L. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol Oncol 99 (2005) 294-300
10. Simcock B., Neesham D., Quinn M., Drummond E., Milner A., and Hicks R.J. The impact of PET/CT in the management of recurrent ovarian cancer. Gynecol Oncol 103 (2006) 271-276
11. Thrall M.M., DeLoia J.A., Gallion H., and Avril N. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. Gynecol Oncol 105 (2007) 17-22
12. Desai D., Arnold M., Saha S., Hinkle G., Soble D., Frye J., et al. Intraoperative gamma detection of FDG distribution in colorectal cancer. Clin Positron Imaging 2 (1999) 325
13. Desai D.C., Arnold M., Saha S., Hinkle G., Soble D., Fry J., et al. Correlative whole-body FDG-PET and intraoperative gamma detection of FDG distribution in colorectal cancer. Clin Positron Imaging 3 (2000) 189-196
14. Sarikaya I., Povoski S.P., Al-Saif O.H., Kocak E., Bloomston M., Marsh S., et al. Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer. World J Surg Oncol 5 (2007) 80
15. Barranger E., Kerrou K., Petegnief Y., David-Montefiore E., Cortez A., and Darai E. Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer. Gynecol Oncol 96 (2005) 241-244.
16. Gulec S.A., Daghighian F., and Essner R. PET-Probe: evaluation of technical performance and clinical utility of a handheld high-energy gamma probe in oncologic surgery. Ann Surg Oncol 24 (2006;July) Electronic publication ahead of print
17. Nwogu C., Fischer G., Tan D., Glinianski M., Lamonica D., and Demmy T. Radioguided detection of lymph node metastasis in non-small cell lung cancer. Ann Thorac Surg 82 (2006) 1815-1820
18. Franc B.L., Mari C., Johnson D., and Leong S.P. The role of a positron- and high-energy gamma photon probe in intraoperative localization of recurrent melanoma. Clin Nucl Med 30 (2005) 787-791
19. Gulec S.A., Hoenie E., Hostetter R., and Schwartzentruber D. PET probe-guided surgery: applications and clinical protocol. World J Surg Oncol 5 (2007) 65
20. Piert M., Burian M., Meisetschlager G., Stein H.J., Ziegler S., Nahrig J., et al. Positron detection for the intraoperative localisation of cancer deposits. Eur J Nucl Med Mol Imaging 34 (2007) 1534-1544
21. Essner R., Daghighian F., and Giuliano A.E. Advances in FDG PET probes in surgical oncology. Cancer J 8 (2002) 100-108
22. Meller B., Sommer K., Gerl J., von Hof K., Surowiec A., Richter E., et al. High energy probe for detecting lymph node metastases with 18F-FDG in patients with head and neck cancer. Nuklearmediziner 45 (2006) 153-159
23. Higashi T., Saga T., Ishimori T., Mamede M., Ishizu K., Fujita T., et al. What is the most appropriate scan timing for intraoperative detection of malignancy using 18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study. Ann Nucl Med 18 (2004) 105-114.
24. 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of occult recurrent metastatic melanoma. World J Surg Oncol 6 (2008) 1